Your session is about to expire
← Back to Search
Finasteride for Enlarged Prostate
Study Summary
This trial is studying why some patients with an enlarged prostate don't respond to the drug finasteride, and if MRI can help predict which patients will respond.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 4 trial • 383 Patients • NCT01296672Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your PSA level is between 1.5 and 40 ng/ml.I have a urinary tract infection right now.I am a biological male.I am eligible for 5-alpha-reductase inhibitor therapy.My prostate is larger than normal as determined by a physical exam.I am 50 years old or older.I have been diagnosed with a type of prostate cancer or precancerous prostate condition.My prostate does not have any lumps, pain, or hardness.I have had radiation therapy to my pelvic area before.I have urinary problems due to an enlarged prostate.I am having a prostate biopsy due to high PSA levels.I have been treated with drugs that affect DNA methylation.I have taken Finasteride or Dutasteride in the last 6 months.I have been diagnosed with a neurological condition like MS, Alzheimer's, or Parkinson's.
- Group 1: Finasteride Treatment
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the population size for this experimental research?
"Affirmative. According to the information recorded on clinicaltrials.gov, this research trial is currently looking for participants; it was initially posted on September 25th 2020 and last updated on January 26th 2022. In total, 120 individuals are being recruited across 1 site."
Are there any current opportunities for participants to join the trial?
"According to the information provided on clinicaltrials.gov, this research is actively enrolling participants. The trial was originally posted on September 25th 2020 and recently updated on January 26th 2022."
What conditions typically require a course of Finasteride?
"Finasteride is a common medication for treating androgenetic alopecia, as well as benign prostatic hyperplasia, hirsutism, and polycystic ovary syndrome."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger